Laurus Labs rallies 6% after reporting highest margin in four quarters
The company reported 20 percent revenue growth versus CNBC-TV18 poll of 7 percent, while margins came in at a four quarter high of 29 percent versus expectation of 27 percent.
A better than expected set of first-quarter earnings for Laurus Labs saw the stock rally by 6.14 percent ending the day at Rs 513.80 per share on NSE.
The company reported 20 percent revenue growth versus the CNBC-TV18 poll of 7 percent, while margins came in at a four-quarter high of 29 percent versus an expectation of 27 percent.
The company’s net profit for the quarter ended June 2022 stood at Rs 251.3 crore versus CNBC-TV18 poll of Rs 211.3 crore.
The growth was led by Synthesis business which grew by 196 percent to Rs 577 crore on a year on year (YoY) basis. While the generic API segment saw a growth of 6 percent YoY.
However the formulations revenues were down 33 percent at Rs 349 crore due to subdued antiretroviral (ARV) business.
The management said they are focusing on strengthening the non-ARV API, formulations and Contract Development & Manufacturing Organization (CDMO) business. They also expect the ARV fixed dose formulations business to grow in the coming quarters.
Watch video for more.
First Published: Jul 27, 2022 8:17 PM IST
Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!
Rapido offers free rides to voters to polling stations on May 13 in Hyderabad, 3 other cities
May 6, 2024 5:49 PM
Lok Sabha elections 2024: Seats to date, all you need to know about third phase of voting
May 6, 2024 4:49 PM
Concerns on low voter turnout a "myth"; absolute number of voters correct way to analyse: Report
May 6, 2024 2:57 PM
Haryana Lok Sabha elections 2024: A look at JJP candidates
May 6, 2024 2:26 PM